Hanson Wade have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause. Register your interest here if you would like updates on the meeting or topic.
What is the Biomolecular Condensates Summit?
The inaugural Biomolecular Condensates Summit is uniting biopharma and academia to address the knowledge gap in understanding the role of biomolecular condensates in disease biology and progression and to advance biomolecular condensates as viable therapeutic targets.
Taking things back to the drawing board, this meeting will seek to re-think the current understanding of condensate defining criteria, explore specific functions of condensates in diseases state and evaluate what role they may play in both neurodegenerative diseases and cancer.
This meeting is built for; medicinal chemistry, molecular biology, pathology and drug discovery functions to tackle the challenges and therapeutically target biomolecular condensates. Sign up today and join the one of the major discovery efforts at the frontier of science.
How Will This Meeting Help you to Therapeutically Target Biomolecular Condensates?
Built for biopharma and academic teams, this meeting provides the opportunity to tackle the biggest roadblocks and uncover new opportunities in biomolecular condensate research and drug discovery.
Hear from pioneering leaders like Merck, Biogen and Amgen across 3 days of in-depth case studies, interactive panel discussions, dedicated Q+A time and highly appraised networking opportunities to meet and learn from those pioneering this emerging field.
What’s more, join our pre-conference workshops for the opportunity to learn from industry leaders in an intimate and discursive session to get the best possible return from your attendance. Check out the full event guide to see what will be discussed!
Why Should You Attend?
Overcoming roadblocks in the development and delivery of clinically predictive markers are vital to delivering on the promise of precision medicine, increasing market share and breaking through competition.
If you are dedicated to further understanding the role of biomolecular condensates in disease biology and progression, developing the appropriate tools to study condensate materials and functions, or therapeutically targeting biomolecular condensates then this is THE place to be! Join the community and establish your self as a pioneer in this emerging field!
Top Speakers Include
Director Neurodegenerative Diseases Discovery
Professor of Chemical & Biological Engineering
Princeton / HHMI
Hear What Attendees at Our Other Events Say
“Very well-organized meeting with an impressive line-up of industry speakers” - Merck
“I was impressed by many of the speakers and learnt a significant amount, which I was able to bring back to our discovery team” - Eisai
“One of the best CNS therapeutics meetings to attend” - P2D Bioscience
“Great list of speakers, nice variety of activities. Perfect size to meet everyone and feel comfortable engaging others” - Novartis